Probiotix Health Plc

As of December 31, 2025, Probiotix Health Plc carries a market capitalization of 1.07B, placing it among publicly traded companies globally. Its enterprise value stands at 941.04M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of December 31, 2025, Probiotix Health Plc has 158.17M shares outstanding.

These figures are as of December 31, 2025.

As of December 31, 2025, Probiotix Health Plc maintains a current ratio of 5.08, meaning it holds 5.1x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended December 31, 2025.

As of the close on October 20, 2026, Probiotix Health Plc's stock has gained approximately 8.18% over the past 52 weeks. The 50-day moving average sits at 9.32, while the 200-day moving average is 7.93.

These figures are as of December 31, 2025. Total book value stands at 144.30M, with working capital of 129.90M providing operational flexibility.